Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Signal Transduction Signaling Pathway G Protein Signaling GPCR

Anti-FPRL1/RFP antibody (ab63023)

Price and availability

284 784 ₸

Availability

Order now and get it on Thursday February 25, 2021

Anti-FPRL1/RFP antibody (ab63023)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Rabbit polyclonal to FPRL1/RFP
  • Suitable for: WB, ICC/IF
  • Reacts with: Human
  • Isotype: IgG

You may also be interested in

Product image
Anti-EDG8 antibody (ab92994)
Product image
Anti-ETL antibody (ab150489)
Product image
Anti-GPR91 antibody (ab41505)
Anti-GPCR LGR6 antibody (ab128257)

Overview

  • Product name

    Anti-FPRL1/RFP antibody
    See all FPRL1/RFP primary antibodies
  • Description

    Rabbit polyclonal to FPRL1/RFP
  • Host species

    Rabbit
  • Tested Applications & Species

    Application Species
    ICC/IF
    Human
    WB
    Human
    See all applications and species data
  • Immunogen

    Synthetic peptide corresponding to Human FPRL1/RFP (C terminal) conjugated to keyhole limpet haemocyanin.

  • Positive control

    • HL60 cells and HL60 cell extract.
  • General notes

     This product was previously labelled as FPRL1

     

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
  • Storage buffer

    pH: 7.20
    Preservative: 0.05% Sodium azide
    Constituents: 0.0268% PBS, 50% Glycerol, 0.01% BSA
  • Concentration information loading...
  • Purity

    Protein G purified
  • Clonality

    Polyclonal
  • Isotype

    IgG
  • Research areas

    • Signal Transduction
    • Signaling Pathway
    • G Protein Signaling
    • GPCR
    • Cardiovascular
    • Atherosclerosis
    • Vascular Inflammation
    • Leukocyte recruitment
    • Cell adhesion molecules

Images

  • Western blot - Anti-FPRL1/RFP antibody (ab63023)
    Western blot - Anti-FPRL1/RFP antibody (ab63023)
    Anti-FPRL1/RFP antibody (ab63023) at 1/6000 dilution + Extracts of HL60 cells

    Predicted band size: 39 kDa
    Observed band size: 38 kDa
    why is the actual band size different from the predicted?

  • Immunocytochemistry/ Immunofluorescence - Anti-FPRL1/RFP antibody (ab63023)
    Immunocytochemistry/ Immunofluorescence - Anti-FPRL1/RFP antibody (ab63023)
    Immunofluorescent analysis of HL60 cells using ab63023 (green) at 1:600. Nucleus have been labeled with PI (red).

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-FPRL1/RFP antibody (ab63023)

  •  
  • Product image

    Anti-FPRL1/RFP antibody - N-terminal (ab229587)

    Applications: WB

  •  
  • Product image

    Anti-FPRL1/RFP antibody (ab203129)

    Applications: Flow Cyt, IHC-P

  •  
  • Product image

    Anti-FPRL1/RFP antibody [GM1D6] (ab26316)

    Applications: Flow Cyt, ICC/IF

  •  
  • Product image

    Anti-FPRL1/RFP antibody (ab63022)

    Applications: Flow Cyt, ICC/IF, WB

Clear all

Recently viewed products

  •  
  • Product image

    Anti-Hsp27 (phospho S85) antibody (ab5594)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.